DOCSLIB.ORG

2014 Progress Report 1 2014 Xxxxx Progress X Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2014 Progress Report 1 2014 Xxxxx Progress X Report XXXXXX 2014 PROGRESS REPORT 1 2014 XXXXX PROGRESS X REPORT DARE TO LOOK BEYOND THE HORIZON 2014 PROGRESS REPORT 3 TABLE OF CONTENTS A Word from the Director 4 A Word from the Scientific Director 5 2013-2018 Strategic Research Plan 6 to 11 Discovery and Hope 12 to 17 The New CHUM Research Centre 18 and 19 The Student Environment: Excellence in the Next Generation 20 and 21 Philanthropy: Supporting Speculative Research and the Next Generation 22 and 23 2013-2014 Financial Picture 24 and 25 Our Committees 26 SEEK OUT WHAT OTHERS FEAR TO TREAD Premiers arrivants Designed expressly to overhang the FRANÇOIS VINCENT CRCHUM entrance hall, this work Painter pays homage to a more sensitive Materials: oil on panels fastened to approach to life. Its simplicity for- hardwood (ash) uprights sakes the complexity of science and Dimensions: 5 panels measuring its grandeur invites the passer-by to 1.4 m. x 1.7 m., the entire piece take a moment to contemplate and measures 5.1 m. in all and is hung look into oneself. 1.8 m. above the ground. This work was chosen within the framework of the Government’s policy geared towards integrating the arts into the architecture and built environ- ment of Government and public sites, which compels any organization that receive grants from the State to set aside at least 1% of their budget to create or purchase works of art. 4 A WORD FROM 2014 PROGRESS REPORT 5 A WORD THE DIRECTORS FROM THE DIRECTORS A WORD FROM A WORD FROM THE THE DIRECTOR SCIENTIFIC DIRECTOR fter six years of tho- possibilities for meaningful exchan- of direct investment made by the he past few years have devotion and passion. They include continuum that characterizes us. rough methodical plan- ges arise daily and participation in Government of Quebec. Over the been transformative researchers, members of our per- The plan also provides several ning and a smoothly numerous conferences in a variety past five years, the CRCHUM bud- and prolific ones for sonnel, students and trainees who strategic initiatives to recruit lea- completed construction of areas is now more than possible. get has erased all previous accumu- the CRCHUM. To begin are conducting innovative research ding world-class researchers, two phase, the CRCHUM lated deficits and now boasts a capi- with, in 2013, we moved projects that are closely linked to of whom have already been suc- Aopened its doors in the fall of 2013. Today, the CRCHUM gives us great tal fund of $4.8 million, in addition Tinto a new complex right in the the health of both individuals and cessfully hired. Accordingly, the Seeing as this project was indispen- pride that all of its researchers wish to a balanced annual budget. heart of Montreal. Naturally, our populations. CRCHUM has reinforced its criti- sable for the continued development to expose to the rest of the world. physical environment is a neces- cal mass in several fields of excel- and outreach mission of our ins- This feeling is embodied by the Dear readers, it gives me immense sary prerequisite to our success, The CRCHUM Scientific Commit- lence, including viral and chronic titution, we very effectively “got it recurring commitment of its stu- pleasure that we may present to you but it is clearly insufficient by itself. tee undertook a comprehensive diseases, translational cell biology right”. The result: our path has been dents, personnel and researchers some of the CRCHUM’s more signi- What make our centre stand out reflection regarding its strengths, and imaging, by recruiting excep- unblemished. The Centre was com- to various fundraising activities. ficant achievements. are all the wonderful people who its focal research themes and its tional researchers from prestigious pleted on time and on budget and For a fifth year now, the CRCHUM come to work there every day with development priorities. This reflec- institutions such as Harvard Medi- now provides technical facilities on Challenge has provided the means tion culminated in cal School and University College the cutting edge of the most modern to raise substantial amounts of the drafting of our London. technologies to more than nineteen money that are redirected towards 2013-2018 Scienti- hundred researchers, students and both student and personnel activi- After six years of thorough fic Plan, which sets Firmly entrenched in its vision of members of the Centre’s personnel. ties. The Grand Labo, that will be Jacques Turgeon out certain goals excellence, the CRCHUM is affir- marking its fifth edition in 2014, B.Pharm, PhD methodical planning and and targets for the ming its place as a major North This new edifice was more than ne- provides an occasion to attract win- Director of the next five years. The American research establishment cessary. Over the past few years, the ners of the Nobel Prize in Medicine CHUM Research Centre a smoothly completed research themes within its university hospital, its CRCHUM has experienced conside- every year, and thereby foster and have been remodel- status as a flagship for the Univer- rable growth in terms of the number fulfil the CRCHUM’s international construction phase, the led, our strengths sité de Montréal Faculty of Medi- of researchers and grants received. potential. This research potential in imaging and cine and its role as a partner who It was morally bound to make the is dedicated to pursuing one single CRCHUM opened its doors engineering have is firmly committed to all of Quebec most of pooling its various areas objective: namely, enabling patients in the fall of 2013. This been consolidated society. We can all be proud. of expertise by bringing together in the Province of Quebec to be the into a new research the different teams who had pre- first to enjoy access to and benefit capital project to develop theme and a matrix viously been scattered over six dif- from cutting edge treatments. structure that fos- ferent sites. Once it was officially and boost the outreach of ters cross-fertili- announced, this project promptly The CRCHUM is also an economic zation between the generated the dynamic that was engine for the Montreal area. With the institution was carried various disciplines eagerly awaited and hoped for by an annual budget of $75 million, it has been adopted to Vincent Poitout all the researchers. Since then, col- helps attract foreign credits, by a out very effectively and we better sustain and D.V.M., PhD laborative projects are flourishing, ratio of five to one, for every dollar “got it right”. The result: nurture the research Scientific Director our path has been unblemished. 6 2013-2018 STRATEGIC 2014 PROGRESS REPORT 7 2013-2018 RESEARCH PLAN STRATEGIC RESEARCH RECONFIGURATION OF THE PLAN FOCAL RESEARCH THEMES THOROUGHLY DANIEL KAUFMANN, MD, INTERRELATED CRCHUM RESEARCHER PRIORITIES To move forward, CRITICAL CRCHUM management has elaborated a 2013-2018 Strategic Research Plan that introduces several major changes. The CRCHUM has chosen to focus one has to work its research priorities on eight specific research themes that are interrelated between one another, so as to create an amalgam of expertise that is perfect- with the best, not POSITIONING ly complementary. The Centre’s research themes have thus been remodel- led in order to develop a critical mass of multidisciplinary expertise in the only in one’s own targeted fields, thereby corresponding to the CHUM’s areas of excellence. research field, but ON THE The priorities that were retained will help entrench even more thoroughly also with other the links between basic, clinical, and population health research activities, while fostering the development of emerging themes. The creation of an specialists. After applied Clinical Research Unit will consolidate clinical and epidemiological WORLD STAGE research. Since the research themes function vis à vis one another as a ma- several years at trix, some of them will explore the specific components of a given pathology, while others will concentrate on transversal approaches. This new vision Harvard, I deci- will thus decompartmentalize various areas of expertise, and now provide the 435 researchers with a unique and high-performance framework that ded to join the CANCER CARDIO- TISSUE INJURY, NEURO- fosters interdisciplinary collaboration. CRCHUM for the METABOLIC IMMUNITY, SCIENCE › Solid tumours INFECTION interrelatedness CRCHUM’S (ovary, breast, › Diabetes and AND INFLAM- › Neuro- prostate, neck) hypertension MATION immunology of the different RESEARCH › Biomarkers › Personalized › Neuro- medecine › Arthrosis and degeneration auto-immunity research themes, PRIORITIES › Aging › Neuro-genetics › Organ transplan- which pool a uni- tation and donation › Chronic viral que amalgam of diseases expertises.” IMAGING AND › Morpho-functional and physical imaging and modelling of biological systems ENGINEERING › Image-guided medical acts › Design, development and validation of new biomaterials and implants Daniel Kaufmann is a physician scientist whose research addresses the human immunodeficiency RISKS Etiological epidemiology: Risks factors › virus (HIV) and the regulation TO HEALTH of the body’s immune system. An internal medicine and GLOBAL HEALTH › Vulnerability and health infectious disease specialist, he has notably worked in EVALUATION, › Health promotion, Chronic disease prevention and management Switzerland, as well as at the CARE SYSTEMS › Improving healthcare delivery prestigious Harvard University. AND SERVICES › Evaluative research ACRU AND CORE FACILITIES 8 2014PLAN DE PROGRESS RECHERCHE REPORT 2013-2018 STRATEGIC 2013-2018 STRATEGIC 2014 PROGRESS REPORT 9 STRATÉGIQUE 2013-2018 RESEARCH PLAN RESEARCH PLAN FOCUS POOLING STATE UPON OF THE ART EMERGING TECHNOLOGY SECTORS PLATFORMS The CRCHUM has In order to implement a genuine concentration of knowledge and excellence that truly creates a unique synergy where everyone identified emerging sectors rubs shoulders together, the CRCHUM took the initiative of poo- in such a way as to cultivate ling its researchers’ equipment. Accordingly, each of them now and nurture the critical has access to 10 cutting edge technology platforms in order to ad- mass and expertise linked vance and develop innovative applications.
Load more

Recommended publications
  • Die Woche Spezial
    In cooperation with DIE WOCHE SPEZIAL >> Autographs>vs.>#NobelSelfie Special >> Big>Data>–>not>a>big>deal,> Edition just>another>tool >> Why>Don’t>Grasshoppers> Catch>Colds? SCIENCE SUMMIT The>64th>Lindau>Nobel>Laureate>Meeting> devoted>to>Physiology>and>Medicine More than 600 young scientists came to Lindau to meet 37 Nobel laureates CAREER WONGSANIT > Women>to>Women: SUPHAKIT > / > Science>and>Family FOTOLIA INFLAMMATION The>Stress>of>Ageing > FLASHPICS > / > MEETINGS > FOTOLIA LAUREATE > CANCER RESEARCH NOBEL > LINDAU > / > J.>Michael>Bishop>and GÄRTNER > FLEMMING > JUAN > / the>Discovery>of>the>first> > CHRISTIAN FOTOLIA Human>Oncogene EDITORIAL IMPRESSUM Chefredakteur: Prof. Dr. Carsten Könneker (v.i.S.d.P.) Dear readers, Redaktionsleiter: Dr. Daniel Lingenhöhl Redaktion: Antje Findeklee, Jan Dönges, Dr. Jan Osterkamp where>else>can>aspiring>young>scientists> Ständige Mitarbeiter: Lars Fischer Art Director Digital: Marc Grove meet>the>best>researchers>of>the>world> Layout: Oliver Gabriel Schlussredaktion: Christina Meyberg (Ltg.), casually,>and>discuss>their>research,>or>their> Sigrid Spies, Katharina Werle Bildredaktion: Alice Krüßmann (Ltg.), Anke Lingg, Gabriela Rabe work>–>or>pressing>global>problems?>Or> Verlag: Spektrum der Wissenschaft Verlagsgesellschaft mbH, Slevogtstraße 3–5, 69126 Heidelberg, Tel. 06221 9126-600, simply>discuss>soccer?>Probably>the>best> Fax 06221 9126-751; Amtsgericht Mannheim, HRB 338114, UStd-Id-Nr. DE147514638 occasion>is>the>annual>Lindau>Nobel>Laure- Geschäftsleitung: Markus Bossle, Thomas Bleck Marketing und Vertrieb: Annette Baumbusch (Ltg.) Leser- und Bestellservice: Helga Emmerich, Sabine Häusser, ate>Meeting>in>the>lovely>Bavarian>town>of> Ute Park, Tel. 06221 9126-743, E-Mail: [email protected] Lindau>on>Lake>Constance. Die Spektrum der Wissenschaft Verlagsgesellschaft mbH ist Kooperati- onspartner des Nationalen Instituts für Wissenschaftskommunikation Daniel>Lingenhöhl> GmbH (NaWik).
    [Show full text]
  • Lecture Program
    EARL W. SUTHERLAND LECTURE EARL W. SUTHERLAND LECTURE The Earl W. Sutherland Lecture Series was established by the SPONSORED BY: Department of Molecular Physiology and Biophysics in 1997 DEPARTMENT OF MOLECULAR PHYSIOLOGY AND BIOPHYSICS to honor Dr. Sutherland, a former member of this department and winner of the 1971 Nobel Prize in Physiology or Medicine. This series highlights important advances in cell signaling. ROBERT J. LEFKOWITZ, MD NOBEL PRIZE IN CHEMISTRY, 2012 SPEAKERS IN THIS SERIES HAVE INCLUDED: SEVEN TRANSMEMBRANE RECEPTORS Edmond H. Fischer (1997) Alfred G. Gilman (1999) Ferid Murad (2001) Louis J. Ignarro (2003) MARCH 31, 2016 Paul Greengard (2007) 4:00 P.M. 208 LIGHT HALL Eric Kandel (2009) Roger Tsien (2011) Michael S. Brown (2013) 867-2923-Institution-Discovery Lecture Series-Lefkowitz-BK-CH.indd 1 3/11/16 9:39 AM EARL W. SUTHERLAND, 1915-1974 ROBERT J. LEFKOWITZ, MD JAMES B. DUKE PROFESSOR, Earl W. Sutherland grew up in Burlingame, Kansas, a small farming community DUKE UNIVERSITY MEDICAL CENTER that nourished his love for the outdoors and fishing, which he retained throughout INVESTIGATOR, HOWARD HUGHES MEDICAL INSTITUTE his life. He graduated from Washburn College in 1937 and then received his MEMBER, NATIONAL ACADEMY OF SCIENCES M.D. from Washington University School of Medicine in 1942. After serving as a MEMBER, INSTITUTE OF MEDICINE medical officer during World War II, he returned to Washington University to train NOBEL PRIZE IN CHEMISTRY, 2012 with Carl and Gerty Cori. During those years he was influenced by his interactions with such eminent scientists as Louis Leloir, Herman Kalckar, Severo Ochoa, Arthur Kornberg, Christian deDuve, Sidney Colowick, Edwin Krebs, Theodore Robert J.
    [Show full text]
  • Michael S. Brown, MD
    DISTINGUISHED PHYSICIANS AND Michael S. Brown, M.D. Sir Richard Roberts, Ph.D. Winner, 1985 Nobel Prize in Physiology or Medicine Winner, 1993 Nobel Prize in Physiology or Medicine MEDICAL SCIENTISTS MENTORING Winner, 1988 Presidential National Medal of Science A globally prominent biochemist and molecular biologist, DELEGATES HAVE INCLUDED... Dr. Brown received the world’s most prestigious medical Dr. Roberts was awarded the Nobel Prize for his prize for his work describing the regulation of the groundbreaking contribution to discovering RNA splicing. cholesterol metabolism. His work laid the foundation for Dr. Roberts is dedicating his future research to GMO crops the class of drugs now called statins taken daily by more than 20 million and food sources, and demonstrating the effect they have on humanity. — GRANDg MASTERS — people worldwide. Ferid Murad, M.D., Ph.D. Mario Capecchi, Ph.D. Boris D. Lushniak, M.D., M.P.H Winner, 1998 Nobel Prize in Physiology or Medicine Academy Science Director The Surgeon General of the United States (acting, 2013-2014) Winner, 2007 Nobel Prize in Physiology or Medicine A world-renowned pioneer in biochemistry, Dr. Murad’s Winner, 2001 National Medal of Science Rear Admiral Lushniak, M.D., M.P.H., was the United award-winning research demonstrated that nitroglycerin Winner, 2001 Lasker Award States’ leading spokesperson on matters of public health, and related drugs help patients with heart conditions by Winner, 2003 Wolf Prize in Medicine overseeing the operations of the U.S. Public Health Service releasing nitric oxide into the body, thus relaxing smooth Mario Capecchi, Ph.D., a biophysicist, is a Distinguished Commissioned Corps, which consists of approximately muscles by elevating intracellular cyclic GMP, leading to vasodilation and Professor of Human Genetics at the University of Utah School of Medicine.
    [Show full text]
  • Earl W. Sutherland Lecture Earl W
    EARL W. SUTHERLAND LECTURE EARL W. SUTHERLAND LECTURE The Earl W. Sutherland Lecture Series was established by the SPONSORED BY: Department of Molecular Physiology and Biophysics in 1997 DEPARTMENT OF MOLECULAR PHYSIOLOGY AND BIOPHYSICS to honor Dr. Sutherland, a former member of this department and winner of the 1971 Nobel Prize in Physiology or Medicine. This series highlights important advances in cell signaling. MICHAEL S. BROWN, M.D NOBEL LAUREATE IN PHYSIOLOGY OR MEDICINE 1985 SPEAKERS IN THIS SERIES HAVE INCLUDED: SCAP: ANATOMY OF A MEMBRANE STEROL SENSOR Edmond H. Fischer (1997) Alfred G. Gilman (1999) Ferid Murad (2001) Louis J. Ignarro (2003) APRIL 25, 2013 Paul Greengard (2007) 4:00 P.M. 208 LIGHT HALL Eric Kandel (2009) Roger Tsien (2011) FOR MORE INFORMATION, CONTACT: Department of Molecular Physiology & Biophysics 738 Ann and Roscoe Robinson Medical Research Building Vanderbilt University Medical Center Nashville, TN 37232-0615 Tel 615.322.7001 [email protected] EARL W. SUTHERLAND, 1915-1974 MICHAEL S. BROWN, M.D. REGENTAL PROFESSOR Earl W. Sutherland grew up in Burlingame, Kansas, a small farming community that nourished his love for the outdoors and fishing, which he retained throughout DIRECTOR OF THE JONSSON CENTER FOR MOLECULAR GENETICS UNIVERSITY OF TEXAS his life. He graduated from Washburn College in 1937 and then received his M.D. SOUTHWESTERN MEDICAL CENTER AT DALLAS from Washington University School of Medicine in 1942. After serving as a medi- NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE, 1985 cal officer during World War II, he returned to Washington University to train with MEMBER, NATIONAL ACADEMY OF SCIENCES Carl and Gerty Cori.
    [Show full text]
  • The Elie Wiesel Foundation for Humanity Nobel
    THE ELIE WIESEL FOUNDATION FOR HUMANITY NOBEL LAUREATES INITIATIVE September 9, 2005 TO: Kansas State Board of Education We, Nobel Laureates, are writing in defense of science. We reject efforts by the proponents of so-called “intelligent design” to politicize scientific inquiry and urge the Kansas State Board of Education to maintain Darwinian evolution as the sole curriculum and science standard in the State of Kansas. The United States has come a long way since John T. Scopes was convicted for teaching the theory of evolution 80 years ago. We are, therefore, troubled that Darwinism was described as “dangerous dogma” at one of your hearings. We are also concerned by the Board’s recommendation of August 8, 2005 to allow standards that include greater criticism of evolution. Logically derived from confirmable evidence, evolution is understood to be the result of an unguided, unplanned process of random variation and natural selection. As the foundation of modern biology, its indispensable role has been further strengthened by the capacity to study DNA. In contrast, intelligent design is fundamentally unscientific; it cannot be tested as scientific theory because its central conclusion is based on belief in the intervention of a supernatural agent. Differences exist between scientific and spiritual world views, but there is no need to blur the distinction between the two. Nor is there need for conflict between the theory of evolution and religious faith. Science and faith are not mutually exclusive. Neither should feel threatened by the other. When it meets in October, 2005, we urge the Kansas State Board of Education to vote against the latest draft of standards, which propose including intelligent design in academic curriculum.
    [Show full text]
  • Nobel Award Stirs up Debate on Nitric Oxide Breakthrough
    news Nobel award stirs up debate on nitric oxide breakthrough [LONDON] The Nobel committee has once again sparked controversy, particularly in Britain, with the award this week of the 1998 8 prize for physiology or medicine to pharma- cologists Robert Furchgott, of the State Uni- versity of New York, Louis Ignarro, of the University of California, Los Angeles, and Ferid Murad, of University of Texas Medical SULLIVAN NADEL/PAT AP/ADAM School in Houston. No-one is disputing that the pioneering work of the three US researchers on nitric oxide as a signalling molecule in the cardio- vascular system (see box) deserves the recog- nition of the committee. But many feel that a The winners: Robert Furchgott (left), Louis Ignarro and Ferid Murad. fourth name should also have been recog- nized — that of Salvador Moncada, currently pharmacology”. Moncada’s achievements edged. But he believes that the prize is thor- director of the Wolfson Institute for Biomed- were recognized when he was elected as a oughly deserved by Furchgott — without ical Research at University College London. foreign associate of the National Academy of whom “the field would not even exist” — The controversy originates in 1987, when Sciences in 1994. The citation says that he and says that he had nominated both Furch- a paper by Ignarro confirming the identity “discovered that mammalian vascular tis- gott and Ignarro for the prize. of endothelium-derived relaxing factor sues generate nitric oxide that is biosynthe- More outspoken support for Moncada (EDRF) and nitric oxide, as had been sized from L-arginine. He elucidated the rel- comes from Nobel laureate Cesar Milstein of hypothesized separately by him and Furch- evance of this pathway as a universal trans- the MRC Laborato- UCL gott, appeared in the Proceedings of the duction mechanism for the regulation of cell ry of Molecular National Academy of Sciences (84, function and communication”.
    [Show full text]
  • Open Letter to the American People
    FOR IMMEDIATE RELEASE: October 18, 2016 AN OPEN LETTER TO THE AMERICAN PEOPLE The coming Presidential election will have profound consequences for the future of our country and the world. To preserve our freedoms, protect our constitutional government, safeguard our national security, and ensure that all members of our nation will be able to work together for a better future, it is imperative that Hillary Clinton be elected as the next President of the United States. Some of the most pressing problems that the new President will face — the devastating effects of debilitating diseases such as Alzheimer’s disease and cancer, the need for alternative sources of energy, and climate change and its consequences — require vigorous support for science and technology and the assurance that scientific knowledge will inform public policy. Such support is essential to this country’s economic future, its health, its security, and its prestige. Strong advocacy for science agencies, initiatives to promote innovation, and sensible immigration and education policies are crucial to the continued preeminence of the U.S. scientific work force. We need a President who will support and advance policies that will enable science and technology to flourish in our country and to provide the basis of important policy decisions. For these reasons and others, we, as U.S. Nobel Laureates concerned about the future of our nation, strongly and fully support Hillary Clinton to be the President of the United States. Peter Agre, Chemistry 2003 Carol W. Greider, Medicine 2009 Sidney Altman, Chemistry 1989 David J. Gross, Physics 2004 Philip W. Anderson, Physics 1977 Roger Guillemin, Medicine 1977 Kenneth J.
    [Show full text]
  • Lasker Interactive Research Nom'18.Indd
    THE 2018 LASKER MEDICAL RESEARCH AWARDS Nomination Packet albert and mary lasker foundation November 1, 2017 Greetings: On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination for the 2018 Lasker Medical Research Awards. Since 1945, the Lasker Awards have recognized the contributions of scientists, physicians, and public citizens who have made major advances in the understanding, diagnosis, treatment, cure, and prevention of disease. The Medical Research Awards will be offered in three categories in 2018: Basic Research, Clinical Research, and Special Achievement. The Lasker Foundation seeks nominations of outstanding scientists; nominations of women and minorities are encouraged. Nominations that have been made in previous years are not automatically reconsidered. Please see the Nomination Requirements section of this booklet for instructions on updating and resubmitting a nomination. The Foundation accepts electronic submissions. For information on submitting an electronic nomination, please visit www.laskerfoundation.org. Lasker Awards often presage future recognition of the Nobel committee, and they have become known popularly as “America’s Nobels.” Eighty-seven Lasker laureates have received the Nobel Prize, including 40 in the last three decades. Additional information on the Awards Program and on Lasker laureates can be found on our website, www.laskerfoundation.org. A distinguished panel of jurors will select the scientists to be honored with Lasker Medical Research Awards. The 2018 Awards will
    [Show full text]
  • Close to the Edge: Co-Authorship Proximity of Nobel Laureates in Physiology Or Medicine, 1991 - 2010, to Cross-Disciplinary Brokers
    Close to the edge: Co-authorship proximity of Nobel laureates in Physiology or Medicine, 1991 - 2010, to cross-disciplinary brokers Chris Fields 528 Zinnia Court Sonoma, CA 95476 USA fi[email protected] January 2, 2015 Abstract Between 1991 and 2010, 45 scientists were honored with Nobel prizes in Physiology or Medicine. It is shown that these 45 Nobel laureates are separated, on average, by at most 2.8 co-authorship steps from at least one cross-disciplinary broker, defined as a researcher who has published co-authored papers both in some biomedical discipline and in some non-biomedical discipline. If Nobel laureates in Physiology or Medicine and their immediate collaborators can be regarded as forming the intuitive “center” of the biomedical sciences, then at least for this 20-year sample of Nobel laureates, the center of the biomedical sciences within the co-authorship graph of all of the sciences is closer to the edges of multiple non-biomedical disciplines than typical biomedical researchers are to each other. Keywords: Biomedicine; Co-authorship graphs; Cross-disciplinary brokerage; Graph cen- trality; Preferential attachment Running head: Proximity of Nobel laureates to cross-disciplinary brokers 1 1 Introduction It is intuitively tempting to visualize scientific disciplines as spheres, with highly produc- tive, well-funded intellectual and political leaders such as Nobel laureates occupying their centers and less productive, less well-funded researchers being increasingly peripheral. As preferential attachment mechanisms as well as the economics of employment tend to give the well-known and well-funded more collaborators than the less well-known and less well- funded (e.g.
    [Show full text]
  • Programme 70Th Lindau Nobel Laureate Meeting 27 June - 2 July 2021
    70 Programme 70th Lindau Nobel Laureate Meeting 27 June - 2 July 2021 Sessions Speakers Access Background Scientific sessions, Nobel Laureates, Clear guidance Everything else social functions, young scientists, to all viewing there is to know partner events, invited experts, and participation for a successful networking breaks moderators options meeting 2 Welcome Two months ago, everything was well on course to celebrate And yet: this interdisciplinary our 70th anniversary with you, in Lindau. anniversary meeting will feature But with the safety and health of all our participants being the most rich and versatile programme ever. of paramount importance, we were left with only one choice: It will provide plenty of opportunity to educate, inspire, go online. connect – and to celebrate! Join us. 4 PARTICIPATING LAUREATES 4 PARTICIPATING LAUREATES 5 Henry A. Joachim Donna George P. Hartmut Michael M. Adam Hiroshi Kissinger Frank Strickland Smith Michel Rosbash Riess Amano Jeffrey A. Peter Richard R. James P. Randy W. Brian K. Barry C. Dean Agre Schrock Allison Schekman Kobilka Barish John L. Harvey J. Robert H. J. Michael Martin J. Hall Alter Grubbs Kosterlitz Evans F. Duncan David J. Ben L. Edmond H. Carlo Brian P. Kailash Elizabeth Haldane Gross Feringa Fischer Rubbia Schmidt Satyarthi Blackburn Robert B. Reinhard Aaron Walter Barry J. Harald Takaaki Laughlin Genzel Ciechanover Gilbert Marshall zur Hausen Kajita Christiane Serge Steven Françoise Didier Martin Nüsslein- Haroche Chu Barré-Sinoussi Queloz Chalfie Volhard Anthony J. Gregg L. Robert J. Saul Klaus William G. Leggett Semenza Lefkowitz Perlmutter von Klitzing Kaelin Jr. Stefan W. Thomas C. Emmanuelle Kurt Ada Konstantin S.
    [Show full text]
  • Nobel Laureates in Physiology Or Medicine
    All Nobel Laureates in Physiology or Medicine 1901 Emil A. von Behring Germany ”for his work on serum therapy, especially its application against diphtheria, by which he has opened a new road in the domain of medical science and thereby placed in the hands of the physician a victorious weapon against illness and deaths” 1902 Sir Ronald Ross Great Britain ”for his work on malaria, by which he has shown how it enters the organism and thereby has laid the foundation for successful research on this disease and methods of combating it” 1903 Niels R. Finsen Denmark ”in recognition of his contribution to the treatment of diseases, especially lupus vulgaris, with concentrated light radiation, whereby he has opened a new avenue for medical science” 1904 Ivan P. Pavlov Russia ”in recognition of his work on the physiology of digestion, through which knowledge on vital aspects of the subject has been transformed and enlarged” 1905 Robert Koch Germany ”for his investigations and discoveries in relation to tuberculosis” 1906 Camillo Golgi Italy "in recognition of their work on the structure of the nervous system" Santiago Ramon y Cajal Spain 1907 Charles L. A. Laveran France "in recognition of his work on the role played by protozoa in causing diseases" 1908 Paul Ehrlich Germany "in recognition of their work on immunity" Elie Metchniko France 1909 Emil Theodor Kocher Switzerland "for his work on the physiology, pathology and surgery of the thyroid gland" 1910 Albrecht Kossel Germany "in recognition of the contributions to our knowledge of cell chemistry made through his work on proteins, including the nucleic substances" 1911 Allvar Gullstrand Sweden "for his work on the dioptrics of the eye" 1912 Alexis Carrel France "in recognition of his work on vascular suture and the transplantation of blood vessels and organs" 1913 Charles R.
    [Show full text]
  • Nobel Laureates Published In
    Nobel Laureates Published in Science has published the research of over 400 Laureates since the award’s inception in 1901! Award categories include Chemistry, Physics, and Medicine. Listed here are prize-winning authors from 1990 to the present, with the number of articles each Laureate published in Science. MEDICINE Articles CHEMISTRY Articles PHYSICS Articles 2015 2016 2014 William C. Campbell . 2 Ben Feringa —Netherlands........................5 Shuji Namakura—Japan .......................... 1 J. Fraser Stoddart—UK . 7 2014 2012 John O’Keefe—US...................................3 2015 Serge Haroche—France . 1 May-Britt Moser—Norway .......................11 Tomas Lindahl—US .................................4 David J. Wineland—US ............................12 Edvard I. Moser—Norway ........................11 Paul Modrich—US...................................4 Aziz Sancar—US.....................................7 2011 2013 Saul Perlmutter—US ............................... 1 2014 James E. Rothman—US ......................... 10 Brian P. Schmidt—US/Australia ................. 1 Eric Betzig—US ......................................9 Randy Schekman—US.............................5 Stefan W. Hell—Germany..........................6 2010 Thomas C. Südhof—Germany ..................13 William E. Moerner—US ...........................5 Andre Geim—Russia/UK..........................6 2012 Konstantin Novoselov—Russia/UK ............5 2013 Sir John B. Gurdon—UK . 1 Martin Karplas—Austria...........................4 2007 Shinya Yamanaka—Japan.........................3
    [Show full text]